RaySearch Laboratories AB (publ) (Nasdaq Stockholm: RAY B), a developer of software solutions for cancer treatment, announced on Monday that it has released RayIntelligence v2025, a major update to its oncology analytics platform.

The system provides clinics with tools to build customised dashboards and integrates more deeply with RaySearch's portfolio, including RayStation and RayCare, enabling continuous learning from patient data to improve treatment outcomes.

By connecting directly to primary oncology data sources, RayIntelligence v2025 consolidates scattered clinical information into a single intelligence layer. Clinics can monitor plan quality, machine utilisation, protocol adherence and outcome trends, allowing clinical teams to optimise workflows and adapt practices in real time.

RaySearch was founded in 2000 as a Karolinska Institute spin-off. Its products, sold to over 1,100 clinics in 47 countries, include the RayStation treatment planning system, the RayCare oncology information system, RayIntelligence for analytics,and RayCommand for treatment control. The company positions data-driven oncology as a pathway to more personalised, evidence-based care.